Epigenetic Mechanisms Underlying the Pathogenesis of Neurogenetic Diseases

Irfan A. Qureshi, Mark F. Mehler

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

There have been considerable advances in uncovering the complex genetic mechanisms that underlie nervous system disease pathogenesis, particularly with the advent of exome and whole genome sequencing techniques. The emerging field of epigenetics is also providing further insights into these mechanisms. Here, we discuss our understanding of the interplay that exists between genetic and epigenetic mechanisms in these disorders, highlighting the nascent field of epigenetic epidemiology—which focuses on analyzing relationships between the epigenome and environmental exposures, development and aging, other health-related phenotypes, and disease states—and next-generation research tools (i.e., those leveraging synthetic and chemical biology and optogenetics) for examining precisely how epigenetic modifications at specific genomic sites affect disease processes.

Original languageEnglish (US)
Pages (from-to)708-720
Number of pages13
JournalNeurotherapeutics
Volume11
Issue number4
DOIs
StatePublished - Oct 18 2014

Fingerprint

Epigenomics
Optogenetics
Synthetic Biology
Exome
Environmental Exposure
Nervous System Diseases
Genome
Phenotype
Health
Research

Keywords

  • Chromatin
  • DNA methylation
  • Epigenetic
  • Epigenome
  • Histone
  • Noncoding RNA

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Pharmacology

Cite this

Epigenetic Mechanisms Underlying the Pathogenesis of Neurogenetic Diseases. / Qureshi, Irfan A.; Mehler, Mark F.

In: Neurotherapeutics, Vol. 11, No. 4, 18.10.2014, p. 708-720.

Research output: Contribution to journalArticle

@article{c88894f512b4485bb0ccab9bdb5143eb,
title = "Epigenetic Mechanisms Underlying the Pathogenesis of Neurogenetic Diseases",
abstract = "There have been considerable advances in uncovering the complex genetic mechanisms that underlie nervous system disease pathogenesis, particularly with the advent of exome and whole genome sequencing techniques. The emerging field of epigenetics is also providing further insights into these mechanisms. Here, we discuss our understanding of the interplay that exists between genetic and epigenetic mechanisms in these disorders, highlighting the nascent field of epigenetic epidemiology—which focuses on analyzing relationships between the epigenome and environmental exposures, development and aging, other health-related phenotypes, and disease states—and next-generation research tools (i.e., those leveraging synthetic and chemical biology and optogenetics) for examining precisely how epigenetic modifications at specific genomic sites affect disease processes.",
keywords = "Chromatin, DNA methylation, Epigenetic, Epigenome, Histone, Noncoding RNA",
author = "Qureshi, {Irfan A.} and Mehler, {Mark F.}",
year = "2014",
month = "10",
day = "18",
doi = "10.1007/s13311-014-0302-1",
language = "English (US)",
volume = "11",
pages = "708--720",
journal = "Neurotherapeutics",
issn = "1933-7213",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Epigenetic Mechanisms Underlying the Pathogenesis of Neurogenetic Diseases

AU - Qureshi, Irfan A.

AU - Mehler, Mark F.

PY - 2014/10/18

Y1 - 2014/10/18

N2 - There have been considerable advances in uncovering the complex genetic mechanisms that underlie nervous system disease pathogenesis, particularly with the advent of exome and whole genome sequencing techniques. The emerging field of epigenetics is also providing further insights into these mechanisms. Here, we discuss our understanding of the interplay that exists between genetic and epigenetic mechanisms in these disorders, highlighting the nascent field of epigenetic epidemiology—which focuses on analyzing relationships between the epigenome and environmental exposures, development and aging, other health-related phenotypes, and disease states—and next-generation research tools (i.e., those leveraging synthetic and chemical biology and optogenetics) for examining precisely how epigenetic modifications at specific genomic sites affect disease processes.

AB - There have been considerable advances in uncovering the complex genetic mechanisms that underlie nervous system disease pathogenesis, particularly with the advent of exome and whole genome sequencing techniques. The emerging field of epigenetics is also providing further insights into these mechanisms. Here, we discuss our understanding of the interplay that exists between genetic and epigenetic mechanisms in these disorders, highlighting the nascent field of epigenetic epidemiology—which focuses on analyzing relationships between the epigenome and environmental exposures, development and aging, other health-related phenotypes, and disease states—and next-generation research tools (i.e., those leveraging synthetic and chemical biology and optogenetics) for examining precisely how epigenetic modifications at specific genomic sites affect disease processes.

KW - Chromatin

KW - DNA methylation

KW - Epigenetic

KW - Epigenome

KW - Histone

KW - Noncoding RNA

UR - http://www.scopus.com/inward/record.url?scp=84919870857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919870857&partnerID=8YFLogxK

U2 - 10.1007/s13311-014-0302-1

DO - 10.1007/s13311-014-0302-1

M3 - Article

C2 - 25261112

AN - SCOPUS:84919870857

VL - 11

SP - 708

EP - 720

JO - Neurotherapeutics

JF - Neurotherapeutics

SN - 1933-7213

IS - 4

ER -